Gene · 186
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic. | Biochem Pharmacol | 2023 | 36481346 | PubTator, text mining | PubMed |
| The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic. | Mol Biol Rep | 2023 | 36478297 | PubTator, text mining | PubMed |
| LRP1 protects against excessive superior mesenteric artery remodeling by modulating angiotensin II-mediated signaling. | JCI Insight | 2023 | 36472907 | PubTator, text mining | PubMed |
| Angiotensin Type 2 Receptor Pharmacological Agonist Relieves Neurocognitive Deficits via Reducing Neuroinflammation and Microglial Engulfment of Dendritic Spines. | J Neuroimmune Pharmacol | 2023 | 36464726 | PubTator, text mining | PubMed |
| Influence of sex on renin-angiotensin-aldosterone system metabolites and enzymes in Doberman Pinschers. | J Vet Intern Med | 2023 | 36412252 | PubTator, text mining | PubMed |
| Metabolic pathways enriched according to ERG status are associated with biochemical recurrence in Hispanic/Latino patients with prostate cancer. | Cancer Med | 2023 | 36329628 | PubTator, text mining | PubMed |
| Zebrafish models of COVID-19. | FEMS Microbiol Rev | 2023 | 36323404 | PubTator, text mining | PubMed |
| Function and structure of bradykinin receptor 2 for drug discovery. | Acta Pharmacol Sin | 2023 | 36075965 | PubTator, text mining | PubMed |
| Novel Biomarkers for Posterior Urethral Valve. | Curr Med Chem | 2023 | 35927803 | PubTator, text mining | PubMed |
| A phase 2 trial investigating the effects of the angiotensin II type 2 receptor agonist C21 in systemic sclerosis-related Raynaud's. | Rheumatology (Oxford) | 2023 | 35894657 | PubTator, text mining | PubMed |
| Carbonic anhydrase inhibitors in the management of macular edema: A review of the literature. | Med Hypothesis Discov Innov Ophthalmol | 2022 | 37641698 | PubTator, text mining | PubMed |
| Angiotensin-Converting Enzyme (ACE) Inhibitors May Moderate COVID-19 Hyperinflammatory Response: An Observational Study with Deep Immunophenotyping. | Health Data Sci | 2022 | 36817759 | PubTator, text mining | PubMed |
| Early Evidence on Genetic Polymorphisms in Conferring A "Two-Hit" Propensity to Renal Injury in Asian Indian Children. | J Indian Assoc Pediatr Surg | 2022 | 36714477 | PubTator, text mining | PubMed |
| A Counterintuitive Neutrophil-Mediated Pattern in COVID-19 Patients Revealed through Transcriptomics Analysis. | Viruses | 2022 | 36680144 | PubTator, text mining | PubMed |
| Alterations in Renin-Angiotensin System (RAS) Peptide Levels in Patients with HIV. | Metabolites | 2022 | 36676986 | PubTator, text mining | PubMed |
| Cardioprotective Mechanisms against Reperfusion Injury in Acute Myocardial Infarction: Targeting Angiotensin II Receptors. | Biomedicines | 2022 | 36672525 | PubTator, text mining | PubMed |
| IgA Nephropathy with Macroproteinuria and a GFR of 20-30 ml/min/1.73 m2 May Still Benefit from RAS Inhibition. | J Renin Angiotensin Aldosterone Syst | 2022 | 36660420 | PubTator, text mining | PubMed |
| Serial femtosecond crystallography. | Nat Rev Methods Primers | 2022 | 36643971 | PubTator, text mining | PubMed |
| The Biology and Function of Tissue Inhibitor of Metalloproteinase 2 in the Lungs. | Pulm Med | 2022 | 36624735 | PubTator, text mining | PubMed |
| Effects and mechanisms of SGLT2 inhibitors on the NLRP3 inflammasome, with a focus on atherosclerosis. | Front Endocrinol (Lausanne) | 2022 | 36589841 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/186/papers?page=12